CIBC World Market’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-73,587
| Closed | -$446K | – | 1285 |
|
|
2024
Q3 | $446K | Sell |
73,587
-6,670
| -8% | -$40.4K | ﹤0.01% | 952 |
|
|
2024
Q2 | $422K | Sell |
80,257
-600
| -0.7% | -$3.16K | ﹤0.01% | 934 |
|
|
2024
Q1 | $686K | Sell |
80,857
-30,843
| -28% | -$262K | ﹤0.01% | 834 |
|
|
2023
Q4 | $737K | Sell |
111,700
-37,443
| -25% | -$247K | ﹤0.01% | 763 |
|
|
2023
Q3 | $461K | Sell |
149,143
-11,500
| -7% | -$35.5K | ﹤0.01% | 841 |
|
|
2023
Q2 | $434K | Sell |
160,643
-48,148
| -23% | -$130K | ﹤0.01% | 882 |
|
|
2023
Q1 | $620K | Buy |
208,791
+43,150
| +26% | +$128K | ﹤0.01% | 787 |
|
|
2022
Q4 | $417K | Buy |
165,641
+88,405
| +114% | +$223K | ﹤0.01% | 859 |
|
|
2022
Q3 | $141K | Sell |
77,236
-17,342
| -18% | -$31.7K | ﹤0.01% | 1067 |
|
|
2022
Q2 | $298K | Sell |
94,578
-20,654
| -18% | -$65.1K | ﹤0.01% | 948 |
|
|
2022
Q1 | $712K | Buy |
115,232
+31,002
| +37% | +$192K | ﹤0.01% | 785 |
|
|
2021
Q4 | $1.2M | Buy |
+84,230
| New | +$1.2M | ﹤0.01% | 670 |
|
|
2021
Q1 | – | Sell |
-10,050
| Closed | -$120K | – | 1243 |
|
|
2020
Q4 | $120K | Hold |
10,050
| – | – | ﹤0.01% | 1142 |
|
|
2020
Q3 | $69K | Hold |
10,050
| – | – | ﹤0.01% | 1012 |
|
|
2020
Q2 | $62K | Hold |
10,050
| – | – | ﹤0.01% | 987 |
|
|
2020
Q1 | $40K | Hold |
10,050
| – | – | ﹤0.01% | 913 |
|
|
2019
Q4 | $55K | Hold |
10,050
| – | – | ﹤0.01% | 1042 |
|
|
2019
Q3 | $34K | Hold |
10,050
| – | – | ﹤0.01% | 1009 |
|
|
2019
Q2 | $25K | Hold |
10,050
| – | – | ﹤0.01% | 1060 |
|
|
2019
Q1 | $34K | Hold |
10,050
| – | – | ﹤0.01% | 1070 |
|
|
2018
Q4 | $21K | Hold |
10,050
| – | – | ﹤0.01% | 1017 |
|
|
2018
Q3 | $30K | Hold |
10,050
| – | – | ﹤0.01% | 1076 |
|
|
2018
Q2 | $38K | Hold |
10,050
| – | – | ﹤0.01% | 1088 |
|
|
2018
Q1 | $769K | Hold |
10,050
| – | – | ﹤0.01% | 687 |
|
|
2017
Q4 | $44K | Hold |
10,050
| – | – | ﹤0.01% | 747 |
|
|
2017
Q3 | $58K | Buy |
+10,050
| New | +$58K | ﹤0.01% | 699 |
|